[Impossible to document adverse effects of calcium antagonists. Effects equal to those of conservative treatment of hypertension].
Nilsson
P
P
Avdelningen för medicin, Universitetssjukhuset MAS, Malmö. Peter.Nilsson@medforsk.mas.lu.se
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000009:adverse effects*; D018849:Controlled Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control; D004232:Diuretics; D004359:Drug Therapy, Combination; D006801:Humans; D012307:Risk Factors; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D020521:Stroke / Q000517:prevention & control
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors